---
title: "GRAIL | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 44.69 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295047856.md"
datetime: "2026-08-06T03:09:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295047856.md)
  - [en](https://longbridge.com/en/news/295047856.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295047856.md)
generator: "portal-rs"
---

# GRAIL | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 44.69 M

Revenue: As of FY2026 Q2, the actual value is USD 44.69 M, beating the estimate of USD 42.4 M.

EPS: As of FY2026 Q2, the actual value is USD -2.56, beating the estimate of USD -2.6556.

EBIT: As of FY2026 Q2, the actual value is USD -166.71 M.

GRAIL, Inc. reported its financial results for the second quarter and first half of 2026.

#### Segment Revenue

-   **Total Revenue (Q2 2026)**: $44.7 million, an increase of $9.1 million or 26% year-over-year.
    -   **Screening Revenue (Q2 2026)**: $42,642 thousand, compared to $34,379 thousand in Q2 2025.
    -   **Development Services Revenue (Q2 2026)**: $2,045 thousand, compared to $1,165 thousand in Q2 2025.
-   **Galleri Test Revenue (Q2 2026)**: $42.6 million, grew 24% year-over-year.
-   **Galleri Test Revenue (H1 2026)**: $82.5 million, grew 30% year-over-year.

#### Operational Metrics

-   **Net Loss (Q2 2026)**: - $110.2 million, an improvement of $3.7 million or 3% compared to - $113.985 million in Q2 2025.
-   **Net Loss (H1 2026)**: - $203,434 thousand, compared to - $220,198 thousand in H1 2025.
-   **Gross Loss (Q2 2026)**: - $12.6 million, an improvement of $5.2 million or 29% compared to - $17,775 thousand in Q2 2025.
-   **Gross Loss (H1 2026)**: - $26,873 thousand, compared to - $37,704 thousand in H1 2025.
-   **Adjusted Gross Profit (Q2 2026)**: $21.6 million, an increase of $5.4 million or 34% compared to $16,114 thousand in Q2 2025.
-   **Adjusted Gross Profit (H1 2026)**: $41,253 thousand, compared to $30,419 thousand in H1 2025.
-   **Adjusted EBITDA (Q2 2026)**: - $90.3 million, an increase in adjusted EBITDA loss of $11.9 million or 15% compared to - $78,322 thousand in Q2 2025.
-   **Adjusted EBITDA (H1 2026)**: - $170,192 thousand, compared to - $177,057 thousand in H1 2025.
-   **Loss from Operations (Q2 2026)**: - $173,783 thousand, compared to - $158,854 thousand in Q2 2025.
-   **Interest Income (Q2 2026)**: $7,230 thousand, compared to $6,809 thousand in Q2 2025.
-   **Benefit from Income Taxes (Q2 2026)**: $56,461 thousand, compared to $38,871 thousand in Q2 2025.

#### Operating Costs (Q2 2026)

-   **Cost of Screening Revenue**: $23,347 thousand, compared to $19,346 thousand in Q2 2025.
-   **Cost of Development Services Revenue**: $434 thousand, compared to $501 thousand in Q2 2025.
-   **Cost of Revenue — Amortization of Intangible Assets**: $33,472 thousand, consistent with Q2 2025.
-   **Research and Development**: $47,429 thousand, compared to $46,626 thousand in Q2 2025.
-   **Sales and Marketing**: $37,657 thousand, compared to $28,539 thousand in Q2 2025.
-   **General and Administrative**: $50,708 thousand, compared to $37,914 thousand in Q2 2025.
-   **Intangible and Other Assets Impairment**: $25,423 thousand, compared to $28,000 thousand in Q2 2025.

#### Cash Position

-   **Cash, cash equivalents, and short-term marketable securities**: $861.6 million as of June 30, 2026.

#### Unique Metrics

-   **Galleri Test Volume (Q2 2026)**: More than 61,000, increased 35% year-over-year.
-   **Galleri Test Volume (H1 2026)**: More than 117,000, increased 42% year-over-year.

#### Outlook / Guidance

GRAIL, Inc. anticipates an FDA advisory committee in the fall to review the Premarket Approval (PMA) application for the Galleri multi-cancer early detection blood test. The company completed a $110 million equity financing with Samsung C&T Corporation and Samsung Electronics Co., Ltd. GRAIL, Inc. intends to collaborate with Samsung C&T to commercialize the Galleri test in South Korea, with potential expansion into other Asian markets subject to regulatory approvals.

### Related Stocks

- [GRAL.US](https://longbridge.com/en/quote/GRAL.US.md)

## Related News & Research

- [Sherwin-Williams announces Q3 2026 dividend of R$ 0.28 per unit](https://longbridge.com/en/news/299050724.md)
- [LOG Commercial Properties publishes financial calendar update for 2026](https://longbridge.com/en/news/298951880.md)
- [ADM announces Q3 2026 dividend of R$ 0.22 per unit](https://longbridge.com/en/news/298917252.md)
- [Ecosuntek adds Q3 KPI update to 2026 corporate events calendar](https://longbridge.com/en/news/298712114.md)
- [Prudential Financial announces R$ 2.41 per unit dividend for Q3 2026 BDRs](https://longbridge.com/en/news/298940810.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**